5-FAM-Amyloid-β (1-42) peptide is a fluorescently labeled amyloid-β peptide. Amyloid-β (1-42) (Aβ42) peptide is the primary form of Aβ found in amyloid plaques in postmortem cerebral cortex from patients with Alzheimer's disease and its aggregation results in the formation of neurotoxic fibrils or globular oligomers. 5-FAM-Amyloid-β (1-42) is a labeled form of Aβ42 containing 5-carboxyfluorescein , which displays excitation/emission maxima of 492/518 nm, respectively.

產(chǎn)品概述產(chǎn)品概述5-FAM-Amyloid-β (1-42) peptide is a fluorescently labeled amyloid-β peptide. Amyloid-β (1-42) (Aβ42) peptide is the primary form of Aβ found in amyloid plaques in postmortem cerebral cortex from patients with Alzheimer's disease and its aggregation results in the formation of neurotoxic fibrils or globular oligomers. 5-FAM-Amyloid-β (1-42) is a labeled form of Aβ42 containing 5-carboxyfluorescein , which displays excitation/emission maxima of 492/518 nm, respectively.SequenceSequence ShorteningDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIAN Terminal5-FAMMolecular Weight4872.36返回產(chǎn)品屬性Purity>95%SolubilitySoluble in 3% ammonia water under 1mg/ml產(chǎn)品形式Lyophilized儲(chǔ)存條件Store at -20°C. Keep tightly closed. Store in a cool dry place.For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.

產(chǎn)品概述

產(chǎn)品概述	5-FAM-Amyloid-β (1-42) peptide is a fluorescently labeled amyloid-β peptide. Amyloid-β (1-42) (Aβ42) peptide is the primary form of Aβ found in amyloid plaques in postmortem cerebral cortex from patients with Alzheimer's disease and its aggregation results in the formation of neurotoxic fibrils or globular oligomers. 5-FAM-Amyloid-β (1-42) is a labeled form of Aβ42 containing 5-carboxyfluorescein , which displays excitation/emission maxima of 492/518 nm, respectively.
Sequence
Sequence Shortening	DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
N Terminal	5-FAM
Molecular Weight	4872.36

返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.